Cochlear™ Nucleus® Kanso® 2 Sound Processor recognised in Good Design Awards for design excellence
22 October, 2021
The winners of Australia’s peak international design awards were announced today during the 2021 Good Design Awards Week. The Good Design Awards reward projects across 12 design disciplines and 30 subcategories.
The Australian Good Design Awards is the country’s oldest and most prestigious international awards for design and innovation with a proud history dating back to 1958. The Awards celebrate the best new products and services on the international market, excellence in architectural design, precinct design, engineering, fashion, digital and communication design, and reward new and emerging areas of design including design strategy, social impact design, design research and up-and-coming design talent in the Next Gen category.
Cochlear™ Nucleus® Kanso® 2 Sound Processor received a prestigious Good Design Award Gold Accolade in the Product Design category in recognition of outstanding design and innovation.
The 2021 Good Design Awards attracted a record number of submissions with 933 design projects evaluated by more than 70 Australian and international jurors, including designers, engineers, architects and thought leaders. Each entry was evaluated according to a strict set of design evaluation criteria which includes good design, design innovation and design impact. Projects recognised with a Good Design Award demonstrated excellence in professional design and highlight the impact a design-led approach has on business success and social and environmental outcomes.
The Good Design Awards Jury commented: “This is an excellent product. The [Cochlear™ Nucleus® Kanso® 2] presents innovation in the Cochlear product line through elegant integration of smart phone connectivity, miniaturisation and simplification of form/function. It's a very good example of a continuous improvement in design, safety and comfort for the user by adopting wireless charging... The product is also very robust and simple, with valuable app features.”
Dr. Brandon Gien, CEO of Good Design Australia said: “Receiving an Australian Good Design Award is testament to embedding design excellence at the heart of a product, service, place or experience. Although 2021 continues to be another challenging year, it is incredibly inspiring to see designers and businesses working together to find innovative, customer-centric design solutions to local and global challenges and to see them recognised and rewarded for their efforts through these prestigious Awards.”
“The importance of embracing good design principles is now more important than ever as many businesses around the world have had to completely re-think their business strategies to remain competitive. The standard of design excellence represented in this year’s Awards is the best I’ve ever seen in my 25 years of running these Awards, an encouraging sign that the design sector is flourishing,” Dr. Gien went on to say.
The Nucleus Kanso 2 Sound Processor is the world’s smallest1 off-the-ear cochlear implant sound processor with proven hearing performance technologies2-5. It is the first and only off-the-ear cochlear implant sound processor to offer direct streaming from compatible Apple or Android™ devices*, and is compatible with the Nucleus Smart App*, enabling control of device settings, functions and information.
The Kanso 2 Sound Processor features an integrated rechargeable battery6 and the highest water resistance rating available† for any off-the-ear cochlear implant sound processor, giving users the freedom to live an active lifestyle.
Project Title: Cochlear™ Nucleus® Kanso® 2 Sound Processor
Designed in: Australia
Project Description: Designed for Cochlear implant recipients and their active lifestyles, the Cochlear Nucleus Kanso 2 Sound Processor is the latest off-the-ear cochlear implant sound processor. This Australian design combines the latest smartphone connectivity features and proven hearing performance technology into a simple and durable all-in-one design.
Designed by: Cochlear Limited
Commissioned by: Cochlear Limited
For further information, please contact: Jennifer Stevenson
Vice President Communications and Brand
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
- Cochlear Limited. D1190805 Sound Processor Size Comparison. 2020; March. Data on file.
- Mauger SJ, et al. Clinical evaluation of the Nucleus 6 cochlear implant system: performance improvements with SmartSound iQ. International Journey of Audiology. (2014 Aug); 53(8): 564-576. [Sponsored by Cochlear].
- Mauger SJ, et al. Clinical outcomes with the Kanso off-the-ear cochlear implant sound processor. Int J Audiol. (2017 Jan); DOI:10.1080/14992027.2016.1265156.
- Wolfe J, et al. Benefits of Adaptive Signal Processing in a Commercially Available Cochlear Implant Sound Processor. Otol Neurotol. (2015 Aug); 36(7):1181-90.
- Cochlear Limited. D1660797. CP1150 Sound Processor Interim Clinical Investigation Report. January 2020
- Cochlear Limited. D1710313 CP1150 Battery Life Coverage Technical Report. 2020; Mar. Data on file.
* The Cochlear Nucleus Kanso 2 Sound Processor is compatible with Apple and Android devices. For compatibility information visit www.cochlear.com/compatibility.
† The Cochlear Kanso 2 Sound Processor is dust and water resistant to level of IP68 of the International Standard IEC60529. The Cochlear Nucleus Kanso 2 Sound Processor with Aqua+ is dust and water resistant to level of IP68 of the International Standard IEC60529 and can be continuously submerged under water to a depth of up to 3 metres for up to 2 hours. Refer to the relevant User Guide for more information.
Apple, the Apple logo, FaceTime, Made for iPad logo, Made for iPhone logo, Made for iPod logo, iPhone, iPad Pro, iPad Air, iPad mini, iPad and iPod touch are trademarks of Apple Inc., registered in the U.S. and other countries.
Android is a trademark of Google LLC. The Android robot is reproduced or modified from work created and shared by Google and used according to terms described in the Creative Commons 3.0 Attribution License.
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc., and any use of such marks by Cochlear Limited is under license.
Cochlear, 科利耳, コクレア, 코클리어, Hear now. And always, Nucleus, Kanso, Advance Off-Stylet, AutoNRT, Contour Advance, Custom Sound, Freedom, NRT, SmartSound, the elliptical logo, and marks bearing an ® or ™ symbol, are either trademarks or registered trademarks of Cochlear Limited (unless otherwise noted).